We are live on
!
Find out more
LIA
LS Investment Advisors Portfolio holdings
AUM
$738M
1-Year Est. Return
29.35%
This Fund
S&P 500
This Quarter
Est. Return
+5.48%
1 Year Est. Return
+29.35%
3 Year Est. Return
+85.73%
5 Year Est. Return
+98.39%
10 Year Est. Return
+364.74%
AUM
$1.56B
AUM Growth
+$143M
(+10%)
Cap. Flow
+$75.9M
Cap. Flow
% of AUM
4.86%
Top 10 Holdings %
Top 10 Hldgs %
14.76%
Holding
1,909
New
32
Increased
697
Reduced
446
Closed
25
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$13M |
| 2 |
Vanguard International High Dividend Yield ETF
VYMI
|
+$4.9M |
| 3 |
PACW
PacWest Bancorp
PACW
|
+$3.33M |
| 4 |
Bank OZK
OZK
|
+$3.22M |
| 5 |
East-West Bancorp
EWBC
|
+$3.12M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Wells Fargo
WFC
|
+$12.7M |
| 2 |
Healthpeak Properties
DOC
|
+$1.33M |
| 3 |
Pfizer
PFE
|
+$1.27M |
| 4 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$1.12M |
| 5 |
LLL
L3 Technologies, Inc.
LLL
|
+$1.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.46% |
| 2 | Technology | 13.76% |
| 3 | Healthcare | 12.99% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Staples | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
Prologis
PLD
$136B
| $799K | 0.05% |
15,402
+3,080
| +25% | +$157K |
|
302
Regeneron Pharmaceuticals
REGN
$77.4B
| $799K | 0.05% |
2,063
+228
| +12% | +$84.5K |
|
303
Constellation Brands
STZ
$22.3B
| $797K | 0.05% |
4,919
+787
| +19% | +$123K |
|
304
Analog Devices
ADI
$179B
| $792K | 0.05% |
9,662
+1,993
| +26% | +$157K |
|
305
Molson Coors Class B
TAP
$7.79B
| $790K | 0.05% |
8,254
+878
| +12% | +$85.7K |
|
306
Fastenal
FAST
$53.5B
| $789K | 0.05% |
61,276
+3,148
| +5% | +$39.5K |
|
307
Marriott International
MAR
$99B
| $789K | 0.05% |
8,373
+938
| +13% | +$81.5K |
|
308
J.M. Smucker
SJM
$13.1B
| $789K | 0.05% |
6,023
+325
| +6% | +$44.2K |
|
309
Ashland
ASH
$3.33B
| $786K | 0.05% |
12,983
-158
| -1% | -$9.16K |
|
310
Vertex Pharmaceuticals
VRTX
$122B
| $786K | 0.05% |
7,188
+509
| +8% | +$44.8K |
|
311
Rockwell Automation
ROK
$52.4B
| $772K | 0.05% |
4,959
-185
| -4% | -$27.6K |
|
312
Tyson Foods
TSN
$21.4B
| $771K | 0.05% |
12,496
+1,117
| +10% | +$70.4K |
|
|
VIAB
313
DELISTED
Viacom Inc. Class B
VIAB
| $768K | 0.05% |
16,478
+1,228
| +8% | +$51.8K |
|
|
CDK
314
DELISTED
CDK Global, Inc.
CDK
| $766K | 0.05% |
11,779
-503
| -4% | -$32.2K |
|
315
Ingredion
INGR
$6.33B
| $764K | 0.05% |
6,344
-169
| -3% | -$20.7K |
|
316
Camden Property Trust
CPT
$11.2B
| $762K | 0.05% |
9,476
-131
| -1% | -$10.8K |
|
|
WR
317
DELISTED
Westar Energy Inc
WR
| $752K | 0.05% |
13,860
-195
| -1% | -$10.6K |
|
318
Regions Financial
RF
$26.3B
| $751K | 0.05% |
51,681
+2,417
| +5% | +$35.7K |
|
|
ATVI
319
DELISTED
Activision Blizzard
ATVI
| $746K | 0.05% |
14,957
+2,179
| +17% | +$95.7K |
|
|
ALXN
320
DELISTED
Alexion Pharmaceuticals
ALXN
| $743K | 0.05% |
6,131
+706
| +13% | +$91K |
|
321
Ametek
AME
$55B
| $733K | 0.05% |
13,557
+1,223
| +10% | +$64.5K |
|
322
Southwest Airlines
LUV
$22.3B
| $729K | 0.05% |
13,552
+1,280
| +10% | +$68.8K |
|
|
VAR
323
DELISTED
Varian Medical Systems, Inc.
VAR
| $729K | 0.05% |
8,003
-13,395
| -63% | -$1.12M |
|
324
KeyCorp
KEY
$24.2B
| $728K | 0.05% |
40,931
+2,728
| +7% | +$49.9K |
|
325
Equinix
EQIX
$103B
| $724K | 0.05% |
1,808
+133
| +8% | +$50.5K |
|
Similar funds
QI
JJBC
CNB
GWS
TWP
CT
SI
HCP
LS Investment Advisors's Q1 2017 Portfolio in Review
As of Q1 2017, LS Investment Advisors held 1,909 positions worth $1.56B, up 10% from $1.42B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
LS Investment Advisors deployed $75.9M of net new capital in Q1 2017, opening 32 new positions and adding to 697 existing holdings. Its largest new stake was Bioverativ Inc. Common Stock: 7,767 shares worth $423K.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Wells Fargo, an estimated $12.7M trimmed.
- LS Investment Advisors's largest Q1 2017 buy was Bioverativ Inc. Common Stock: 7,767 shares worth $423K.
- LS Investment Advisors added most to Bank of America in Q1 2017, an estimated $13M increase.
- LS Investment Advisors's biggest Q1 2017 reduction was Wells Fargo, cutting an estimated $12.7M.
- LS Investment Advisors fully exited Spectra Energy Corp Wi in Q1 2017, selling an estimated $644K.
- LS Investment Advisors's ten largest holdings make up 15% of its $1.56B portfolio in Q1 2017.
- LS Investment Advisors opened 32 new positions and closed 25 in Q1 2017.
- LS Investment Advisors's portfolio value rose 10% quarter-over-quarter to $1.56B.
Based on LS Investment Advisors's 13F filing for Q1 2017, filed 4 May 2017.